Navigation Links
GeoVax to Webcast Its Presentation at the BIO CEO & Investor 2009 Conference
Date:2/4/2009

d additional support to GeoVax AIDS vaccine development program with a $15 million IPCAVD grant awarded in late 2007.

Safe Harbor Statement

All statements in this news release, not statements of historical fact, are forward-looking statements. These statements are based on expectations and assumptions on the date of this press release and are subject to numerous risks and uncertainties which could cause actual results to differ materially from those described in the forward-looking statements. Risks and uncertainties include, but are not limited to, whether: GeoVax can develop and manufacture these vaccines with the desired characteristics in a timely manner, GeoVax's vaccines will be safe for human use, GeoVax's vaccines will effectively prevent AIDS in humans, vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more effective or easier to use than GeoVax's products, and other factors over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements, and does not intend to do so. Certain matters discussed in this news release are forward-looking statements involving certain risks and uncertainties including, without limitation, risks detailed in the Company's Securities and Exchange Commission filings and reports.


'/>"/>
SOURCE GeoVax Labs, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update
2. U.S. Government Awards $15 Million Grant to GeoVax Labs HIV/AIDS Vaccine Program
3. GeoVax Further Strengthens Management Team
4. GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update
5. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
6. GeoVax Presents Data at AIDS Vaccine 2008 Conference
7. GeoVaxs DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial
8. GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
9. GeoVax to Present at the BIO CEO & Investor Conference 2009
10. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
11. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009).../PRNewswire-FirstCall/--NeogenCorporation(Nasdaq: ...electedtoNeogen,sBoardofDirectorsatthecompany,srec...rethan40yearsofexperienceinthefood,agriculture,and...sorofagriculturaleconomicsatVirginiaTechUniversity...schiefagriculturenegotiatorwiththerankofambassador...
(Date:11/23/2009)...Nov.23/PRNewswire/--Frost&Sullivan,theGrowthPa...nstratingleadershipandinnovationThursday,November1...anquetheldinSanAntonio,Texas. ,, (Logo: http://..., TheHealthcareInnovationAwardsaregiventocompanie...andmanagementofhealthcare.Suchcompanieshaveshownsu...
(Date:11/20/2009)...ountries have an opportunity to take the lead in t...he University of Valencia (UV), working together w...ctive fabric of the Spanish biotechnology industry...sectors have more clout than those in English-spea...od and plants has been overlooked by the leading c...
(Date:11/20/2009)..., November 20 Karolinska Developme... Fund (EIF) has entered into a,co-investment agree... be,managed by Karolinska Development and used to ...harmaceutical and medical technology companies. EI...stment fund. The agreement,represents EIF,s larges...
Breaking Biology Technology:Richard T. Crowder Joins Neogen's Board of Directors 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3Spanish biotechnology should focus on food and plant sectors to be more competitive 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3
..., Mass., Feb. 25 Idenix,Pharmaceuticals, Inc. (Na...,in the discovery and development of drugs for the...eases, announced today that three abstracts have,b...eeting of the European,Association for the Study o...l 23 - 27, 2008. Full abstracts can now be viewed ...
...nd., Feb. 25 Symmetry Medical Inc.,(NYSE: SMA ),... orthopedic,device industry and other medical mark...t and Chief Executive Officer, is scheduled to pre...Conference at The Mission Bay,Conference Center at...008,at 1:50 p.m. PT (4:50 p.m. ET)., A live Web c...
...RDALE, Fla., Feb. 25 The International,Confocal M...edical,professionals and students, has been formed...d use of reflective confocal microscopy (RCM) in,p...ming new members worldwide.,Dermatologists, dermas...,other professionals interested in learning more a...
Other Biology Technology:Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL) 2Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL) 3Symmetry Medical to Present at Canaccord Adams Small-Cap Orthopedics Conference 2International Confocal Microscopy Working Group Established to Advance Practice of Reflective Confocal Microscopy 2
(Date:11/23/2009)...new study provides "incontrovertible evidence" tha...d of Sumatra about 73,000 years ago deforested muc...enter, researchers report. , The volcano ejected... atmosphere, leaving a crater (now the world,s lar...d 35 kilometers wide. Ash from the event has been ...
(Date:11/23/2009)... A new study by University of Alabama at Birmingha...I) and co-existing medical conditions (co-morbidit...among African-Americans compared to Caucasians who...line Nov. 23 in Cancer , a journal of the America...lthough BMI and co-morbidity are independent predi...
(Date:11/23/2009)...ring of recent discoveries about the multiple heal...his multi-purpose nutrient, increased awareness of...t, spurred research and even led to an appreciatio...nging from the health of your immune system to pre... influenza, vitamin D is now seen as one of the mo...
Breaking Biology News(10 mins):Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3U of M plant scientist uncovers clues to yield boosting quirks of corn genome 10826 1U of M plant scientist uncovers clues to yield boosting quirks of corn genome 10826 2Nanotube defects equal better energy and storage systems 14928 1Nanotube defects equal better energy and storage systems 14928 2New maize map to aid plant breeding efforts 10824 1
...Bulletin Board: BMRX) a leading provider of biomet...it has acquired a patent that covers the,adaptatio... The company believes that this patent is valuable...umers have been using portable locks, such as,padl...ongings in lockers,and storage cabinets. These tra...
...in Use, Including Large Scale, Election Enrollme... be Demonstrated, WA...C Bulletin Board: BKYI), a leader in finger-based ...y, announced today that the company,is showcasing ...ations at,the 2007 Biometric Technology Expo, bein...
...TM) 3.1 SP3 to expand Novell, Modular Authenticat...ds, AUSTIN, Texas, Sept. 20 SAFmodule for NMAS(T...ication to Novell(R) eDirectory,networks by coupli...ll,s,Novell Modular Authentication Service (NMAS(T...rectory, Novell,s market-leading directory service...
Other Biology News:bioMETRX, Inc. Acquires Patent for Biometric Padlock 2BIO-key(R) International to Showcase Deployed Biometric Security Applications at 2007 Biometric Technology Expo 2BIO-key(R) International to Showcase Deployed Biometric Security Applications at 2007 Biometric Technology Expo 3IdentiPHI Re Launches SAFmodule Software to Secure Novell(R) Networks 2
Rat Complement Lyophilized Powder from Equitech-Bio
Human Atherosclerosis Antibody Array I Kit, ChemiArray, 20 cytokines per membrane from CHEMICON
High-Binding EIA 96 Well Plates from Cayman Chemical
Complement, Guinea Pig Serum from Calbiochem
Biology Products: